Journal of Neuro-Oncology

, Volume 101, Issue 1, pp 75–81 | Cite as

Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances

  • Paola Angelini
  • Cynthia Hawkins
  • Normand Laperriere
  • Eric Bouffet
  • Ute Bartels
Clinical Study – Patient Study


The concept of organ donation for research purposes has evolved to overcome limited availability of tissue and foster research, in particular in diseases for which surgery is not routinely performed. Diffuse intrinsic pontine glioma (DIPG) is an almost invariably fatal childhood tumour, not amenable to surgery because of its location and infiltrative nature. We report our institutional experience of post mortem brain or tumour donation and its impact on the families. Since July 2002, we have requested permission for post mortem brain examination for research purposes, from parents whose children succumbed to DIPG. Brain donation was discussed with 21 of 27 families of patients diagnosed with DIPG between July 2002 and June 2008 at the Hospital for Sick Children. Ten (47.6%) agreed, and autopsy was performed in 9 cases. Eight of these children died at home, one in the hospital. Autopsy was performed within 48 h from death in all cases except one. Pathological diagnosis was PNET in two and glioblastoma multiforme in seven patients. A disclosure of autopsy results was provided to all parents by the neuro-oncology team. None of the families expressed distress from the autopsy, or regretted the choice made. Autopsy limited to the brain did not interfere with the choices related to palliation. The families derived comfort from the hope that scientific breakthroughs could be made and felt that they were helping to make a difference in the future management of DIPG.


Diffuse intrinsic pontine glioma Autopsy Consent 



We are thankful to all the families and the patients in the Paediatric Brain Tumour Program at SickKids and all neuro-oncology team members. Without their support and efforts this work could not have been done.


  1. 1.
    Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248CrossRefPubMedGoogle Scholar
  2. 2.
    Pincus DW, Richter EO, Yachnis AT, Bennett J, Bhatti MT, Smith A (2006) Brainstem stereotactic biopsy sampling in children. J Neurosurg 104:108–114PubMedGoogle Scholar
  3. 3.
    Cartmill M, Punt J (1999) Diffuse brain stem glioma. A review of stereotactic biopsies. Childs Nerv Syst 15:235–237CrossRefPubMedGoogle Scholar
  4. 4.
    Roujeau T, Machado G, Garnett MR, Miquel C, Puget S, Geoerger B, Grill J, Boddaert N, Di Rocco F, Zerah M, Sainte-Rose C (2007) Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg 107:1–4CrossRefPubMedGoogle Scholar
  5. 5.
    Fisher PG, Breiter SN, Carson BS, Wharam MD, Williams JA, Weingart JD, Foer DR, Goldthwaite PT, Tihan T, Burger PC (2000) A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer 89:1569–1576CrossRefPubMedGoogle Scholar
  6. 6.
    Hargrave D, Chuang N, Bouffet E (2008) Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol 86:313–319CrossRefPubMedGoogle Scholar
  7. 7.
    Kwon JW, Kim IO, Cheon JE, Kim WS, Moon SG, Kim TJ, Chi JG, Wang KC, Chung JK, Yeon KM (2006) Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation. Pediatr Radiol 36:959–964CrossRefPubMedGoogle Scholar
  8. 8.
    Leach PA, Estlin EJ, Coope DJ, Thorne JA, Kamaly-Asl ID (2008) Diffuse brainstem gliomas in children: should we or shouldn’t we biopsy? Br J Neurosurg 22:619–624CrossRefPubMedGoogle Scholar
  9. 9.
    Zagzag D, Miller DC, Knopp E, Farmer JP, Lee M, Biria S, Pellicer A, Epstein FJ, Allen JC (2000) Primitive neuroectodermal tumors of the brainstem: investigation of seven cases. Pediatrics 106:1045–1053CrossRefPubMedGoogle Scholar
  10. 10.
    Burton JL, Underwood JC (2003) Necropsy practice after the “organ retention scandal”: requests, performance, and tissue retention. J Clin Pathol 56:537–541CrossRefPubMedGoogle Scholar
  11. 11.
    Burton EC, Troxclair DA, Newman WP III (1998) Autopsy diagnoses of malignant neoplasms: how often are clinical diagnoses incorrect? JAMA 280:1245–1248CrossRefPubMedGoogle Scholar
  12. 12.
    Chariot P, Witt K, Pautot V, Porcher R, Thomas G, Zafrani ES, Lemaire F (2000) Declining autopsy rate in a French hospital: physician’s attitudes to the autopsy and use of autopsy material in research publications. Arch Pathol Lab Med 124:739–745PubMedGoogle Scholar
  13. 13.
    Hull MJ, Nazarian RM, Wheeler AE, Black-Schaffer WS, Mark EJ (2007) Resident physician opinions on autopsy importance and procurement. Hum Pathol 38:342–350CrossRefPubMedGoogle Scholar
  14. 14.
    Bradbury J, Weber W (1999) Consent requirements for necropsy may change in UK. Lancet 354:2055CrossRefPubMedGoogle Scholar
  15. 15.
    Ramsay S (2001) 105,000 body parts retained in the UK, census says. Lancet 357:365CrossRefPubMedGoogle Scholar
  16. 16.
    Mayor S (2003) Inquiry finds brains were removed without consent. Br Med J 326:1051CrossRefGoogle Scholar
  17. 17.
    Klaiman MH (2005) Whose brain is it anyway? The comparative law of post-mortem organ retention. J Leg Med 26:475–490CrossRefPubMedGoogle Scholar
  18. 18.
    Millar T, Walker R, Arango JC, Ironside JW, Harrison DJ, MacIntyre DJ, Blackwood D, Smith C, Bell JE (2007) Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol 213:369–375CrossRefPubMedGoogle Scholar
  19. 19.
    Bell JE, Alafuzoff I, Al Sarraj S, Arzberger T, Bogdanovic N, Budka H, Dexter DT, Falkai P, Ferrer I, Gelpi E, Gentleman SM, Giaccone G, Huitinga I, Ironside JW, Klioueva N, Kovacs GG, Meyronet D, Palkovits M, Parchi P, Patsouris E, Reynolds R, Riederer P, Roggendorf W, Seilhean D, Schmitt A, Schmitz P, Streichenberger N, Schwalber A, Kretzschmar H (2008) Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol 115:497–507CrossRefPubMedGoogle Scholar
  20. 20.
    Kurosu M, Mukai T, Ohno Y (2003). Regulations and guidelines on handling human materials obtained from medico-legal autopsy for use in research. Leg Med (Tokyo) 5 Suppl 1:S76–S78Google Scholar
  21. 21.
    Azizi L, Garrick TM, Harper CG (2006) Brain donation for research: strong support in Australia. J Clin Neurosci 13:449–452CrossRefPubMedGoogle Scholar
  22. 22.
    Ghorpade A, Bruch L, Persidsky Y, Chin B, Brown WH, Borgmann K, Persidsky R, Wu L, Holter S, Cotter R, Faraci J, Heilman D, Meyer V, Potter JF, Swindells S, Gendelman HE (2005) Development of a rapid autopsy program for studies of brain immunity. J Neuroimmunol 163:135–144CrossRefPubMedGoogle Scholar
  23. 23.
    Garrick T, Howell S, Terwee P, Redenbach J, Blake H, Harper C (2006) Brain donation for research: who donates and why? J Clin Neurosci 13:524–528CrossRefPubMedGoogle Scholar
  24. 24.
    Millar T, Lerpiniere C, Walker R, Smith C, Bell JE (2008) Postmortem tissue donation for research: a positive opportunity? Br J Nurs 17:644–649PubMedGoogle Scholar
  25. 25.
    Buckner T, Blatt J, Smith SV (2006) The autopsy in pediatrics and pediatric oncology: a single-institution experience. Pediatr Dev Pathol 9:374–380CrossRefPubMedGoogle Scholar
  26. 26.
    Sirkia K, Saarinen-Pihkala UM, Hovi L, Sariola H (1998) Autopsy in children with cancer who die while in terminal care. Med Pediatr Oncol 30:284–289CrossRefPubMedGoogle Scholar
  27. 27.
    Hayward RM, Patronas N, Baker EH, Vezina G, Albert PS, Warren KE (2008) Inter-observer variability in the measurement of diffuse intrinsic pontine gliomas. J Neurooncol 90:57–61CrossRefPubMedGoogle Scholar
  28. 28.
    Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, Bouffet E, Hawkins C (2010) Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol. 28(8):1337–1344Google Scholar
  29. 29.
    Thayyil S, Robertson NJ, Scales A, Weber MA, Jacques TS, Sebire NJ, Taylor AM (2009) Prospective parental consent for autopsy research following sudden unexpected childhood deaths: a successful model. Arch Dis Child 94:354–358CrossRefPubMedGoogle Scholar
  30. 30.
    Stevens M (1998) Factors influencing decisions about donation of the brain for research purposes. Age Ageing 27:623–629CrossRefPubMedGoogle Scholar
  31. 31.
    Kreicbergs U, Valdimarsdottir U, Onelov E, Henter JI, Steineck G (2004) Talking about death with children who have severe malignant disease. N Engl J Med 351:1175–1186CrossRefPubMedGoogle Scholar
  32. 32.
    Hilden JM, Watterson J, Chrastek J (2003) Tell the children. J Clin Oncol 21:37s–39sCrossRefPubMedGoogle Scholar
  33. 33.
    Massimo LM, Wiley TJ, Casari EF (2004) From informed consent to shared consent: a developing process in paediatric oncology. Lancet Oncol 5:384–387CrossRefPubMedGoogle Scholar
  34. 34.
    Clements PT, Vigil GJ, Manno MS, Henry GC, Wilks J, Das S, Kellywood R, Foster W (2003) Cultural perspectives of death, grief, and bereavement. J Psychosoc Nurs Ment Health Serv 41:18–26PubMedGoogle Scholar
  35. 35.
    Gordijn SJ, Erwich JJ, Khong TY (2007) The perinatal autopsy: pertinent issues in multicultural Western Europe. Eur J Obstet Gynecol Reprod Biol 132:3–7CrossRefPubMedGoogle Scholar
  36. 36.
    Chichester M (2007) Requesting perinatal autopsy: multicultural considerations. MCN Am J Matern Child Nurs 32:81–86CrossRefPubMedGoogle Scholar
  37. 37.
    Hechler T, Blankenburg M, Friedrichsdorf SJ, Garske D, Hubner B, Menke A, Wamsler C, Wolfe J, Zernikow B (2008) Parents’ perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer. Klin Padiatr 220:166–174CrossRefPubMedGoogle Scholar
  38. 38.
    Dussel V, Kreicbergs U, Hilden JM, Watterson J, Moore C, Turner BG, Weeks JC, Wolfe J (2009) Looking beyond where children die: determinants and effects of planning a child’s location of death. J Pain Symptom Manag 37:33–43CrossRefGoogle Scholar
  39. 39.
    Oppewal F, Meyboom-de Jong B (2001) Family members’ experiences of autopsy. Fam Pract 18:304–308CrossRefPubMedGoogle Scholar
  40. 40.
    Nishio S, Fukui M, Tateishi J (1988) Brain stem gliomas: a clinicopathological analysis of 23 histologically proven cases. J Neurooncol 6:245–250CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Paola Angelini
    • 1
  • Cynthia Hawkins
    • 2
  • Normand Laperriere
    • 3
  • Eric Bouffet
    • 4
  • Ute Bartels
    • 4
  1. 1.Division of Paediatric Haematology and OncologyThe Hospital for Sick ChildrenTorontoCanada
  2. 2.Division of PathologyThe Hospital for Sick ChildrenTorontoCanada
  3. 3.Department of Radiation Oncology, Princess Margaret HospitalUniversity of TorontoTorontoCanada
  4. 4.Paediatric Brain Tumour ProgramThe Hospital for Sick ChildrenTorontoCanada

Personalised recommendations